Company Data

Context Therapeutics Inc.

Ticker
CNTX
Current Price
$1.4 2.19%
Market Cap
$22.4M
Price Target
Refer to Report
Volume
80.6K
52wk Range
$0.95 - $10.87
Advanced Market Data

Overview

Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.